Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 2/3 1Phase 1/2 1Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Multiple Myeloma 5Leukemia 5Leukemia, Myeloid, Acute 4Neoplasms, Plasma Cell 3Leukemia, Promyelocytic, Acute 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Myelodysplastic Syndromes 2Lymphoma 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2Gliosarcoma 2Glioblastoma 2Central Nervous System Neoplasms 2Burkitt Lymphoma 2Astrocytoma 2Waldenstrom Macroglobulinemia 1Unspecified Adult Solid Tumor, Protocol Specific 1Thrombocythemia, Essential 1Sezary Syndrome 1Recurrence 1Rectal Neoplasms 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Oligodendroglioma 1Neoplasm Metastasis 1

Interventions

fludarabine phosphate 14Whole-Body Irradiation 8Mycophenolic Acid 8Peripheral Blood Stem Cell Transplantation 7Cyclosporine 6Cyclophosphamide 6Cytarabine 5Azacitidine 4Thiotepa 3Tacrolimus 3Filgrastim 3Antilymphocyte Serum 3tipifarnib 2laromustine 2aldesleukin 2Methylprednisolone 2Etoposide 2Cyclosporins 2Cord Blood Stem Cell Transplantation 2Bortezomib 2Biopsy 24-phenylbutyric acid 23-aminopyridine-2-carboxaldehyde thiosemicarbazone 2venetoclax 1sargramostim 1lintuzumab 1itacitinib 1ispinesib 1ilorasertib 1fludarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Anemia, Refractory, with Excess of Blasts × Arsenic Trioxide × Clear all
NCT00234000 2020-07-31

Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes

Jonsson Comprehensive Cancer Center

Phase 1 Terminated
1 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡